Yu‐Jing Liang

The diagnostic and prognostic values of plasma Epstein‐Barr virus DNA for residual cervical lymphadenopathy in nasopharyngeal carcinoma patients: a retrospective study

Sai‐Lan Liu, Xiaoyun Li, Lin‐Quan Tang et al. · Cancer Communications · 2019 · 34 citations · Full text

Medicine, Oncology, Pathology +15

The role of capecitabine as maintenance therapy in <i>de novo</i> metastatic nasopharyngeal carcinoma: A propensity score matching study

Sai‐Lan Liu, Yu‐Jing Liang, Qiuyan Chen et al. · Cancer Communications · 2020 · 28 citations · Full text

Medicine, Oncology, Radiation Oncology +13

Individualized concurrent chemotherapy by pretreatment plasma Epstein‐Barr viral DNA in II‐III stage nasopharyngeal carcinoma: A propensity score matching analysis using a large cohort

Wenhui Chen, Sai‐Lan Liu, Yu‐Jing Liang et al. · Cancer Medicine · 2019 · 19 citations · Full text

Medicine, Oncology, Radiation Oncology +13

Identifying distinct risks of treatment failure in nasopharyngeal carcinoma: Study based on the dynamic changes in peripheral blood lymphocytes, monocytes, N classification, and plasma Epstein‐Barr virus <scp>DNA</scp>

Li‐Ting Liu, Yu‐Jing Liang, Shanshan Guo et al. · Head & Neck · 2021 · 17 citations

Medicine, Oncology, Cancer Immunology +16